BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mackley MP, Fletcher B, Parker M, Watkins H, Ormondroyd E. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies. Genet Med 2017;19:283-93. [PMID: 27584911 DOI: 10.1038/gim.2016.109] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Sanderson SC, Hill M, Patch C, Searle B, Lewis C, Chitty LS. Delivering genome sequencing in clinical practice: an interview study with healthcare professionals involved in the 100 000 Genomes Project. BMJ Open 2019;9:e029699. [PMID: 31685495 DOI: 10.1136/bmjopen-2019-029699] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
2 Rahimzadeh V, Knoppers BM, Bartlett G. Ethical, Legal, and Social Issues (ELSI) of Responsible Data Sharing Involving Children in Genomics: A Systematic Literature Review of Reasons. AJOB Empir Bioeth 2020;11:233-45. [PMID: 32975491 DOI: 10.1080/23294515.2020.1818875] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
3 Tallapaka K, Aggarwal S, Bhattacherjee A, Das Bhowmik A, Dalal A. Co-Occurrence of Leber Congenital Amaurosis and Meckel Syndrome Type 1 in a Fetus: Is There a Lesson to Be Learned? Mol Syndromol 2019;10:177-82. [PMID: 31191208 DOI: 10.1159/000496280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Woudstra A, Dondorp W, de Wert G. Stakeholder views on opportunistic genomic screening in the Netherlands: a qualitative study. Eur J Hum Genet 2021;29:949-56. [PMID: 33619333 DOI: 10.1038/s41431-021-00828-7] [Reference Citation Analysis]
5 Miller DT, Lee K, Gordon AS, Amendola LM, Adelman K, Bale SJ, Chung WK, Gollob MH, Harrison SM, Herman GE, Hershberger RE, Klein TE, McKelvey K, Richards CS, Vlangos CN, Stewart DR, Watson MS, Martin CL; ACMG Secondary Findings Working Group. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2021;23:1391-8. [PMID: 34012069 DOI: 10.1038/s41436-021-01171-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
6 Ackerman SL, Koenig BA. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories. AJOB Empirical Bioethics 2017;9:48-57. [DOI: 10.1080/23294515.2017.1405095] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
7 Etchegary H, Winsor M, Power A, Simmonds C. Public engagement with genomic medicine: a summary of town hall discussions. J Community Genet 2021;12:27-35. [PMID: 32865775 DOI: 10.1007/s12687-020-00485-1] [Reference Citation Analysis]
8 Mackley M, McGuire K, Taylor J, Watkins H, Ormondroyd E. From Genotype to Phenotype. Circ Genom Precis Med 2018;11:e002316. [PMID: 30354302 DOI: 10.1161/CIRCGEN.118.002316] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
9 Bombard Y, Clausen M, Shickh S, Mighton C, Casalino S, Kim THM, Muir SM, Carlsson L, Baxter N, Scheer A, Elser C, Eisen A, Panchal S, Graham T, Aronson M, Piccinin C, Mancuso T, Semotiuk K, Evans M, Carroll JC, Offit K, Robson M, Hamilton JG, Glogowski E, Schrader K, Kim RH, Lerner-Ellis J, Thorpe KE, Laupacis A; Incidental Genomics Study Team. Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial. Genet Med 2020;22:727-35. [PMID: 31822848 DOI: 10.1038/s41436-019-0702-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
10 Hawranek C, Hajdarevic S, Rosén A. A Focus Group Study of Perceptions of Genetic Risk Disclosure in Members of the Public in Sweden: "I'll Phone the Five Closest Ones, but What Happens to the Other Ten?". J Pers Med 2021;11:1191. [PMID: 34834542 DOI: 10.3390/jpm11111191] [Reference Citation Analysis]
11 Cléophat JE, Dorval M, El Haffaf Z, Chiquette J, Collins S, Malo B, Fradet V, Joly Y, Nabi H. Whether, when, how, and how much? General public's and cancer patients' views about the disclosure of genomic secondary findings. BMC Med Genomics 2021;14:167. [PMID: 34174888 DOI: 10.1186/s12920-021-01016-8] [Reference Citation Analysis]
12 Ormondroyd E, Harper AR, Thomson KL, Mackley MP, Martin J, Penkett CJ, Salatino S, Stark H, Stephens J, Watkins H. Secondary findings in inherited heart conditions: a genotype-first feasibility study to assess phenotype, behavioural and psychosocial outcomes. Eur J Hum Genet 2020;28:1486-96. [PMID: 32686758 DOI: 10.1038/s41431-020-0694-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Dow E, Freimund A, Smith K, Hicks RJ, Jurcevic P, Shackleton M, James PA, Fellowes A, Delatycki MB, Fawcett S, Flowers N, Pertile MD, McGillivray G, Mileshkin L. Cancer Diagnoses Following Abnormal Noninvasive Prenatal Testing: A Case Series, Literature Review, and Proposed Management Model. JCO Precis Oncol 2021;5:1001-12. [PMID: 34994626 DOI: 10.1200/PO.20.00429] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Lewis C, Sanderson S, Hill M, Patch C, Searle B, Hunter A, Chitty LS. Parents' motivations, concerns and understanding of genome sequencing: a qualitative interview study. Eur J Hum Genet 2020;28:874-84. [PMID: 32001839 DOI: 10.1038/s41431-020-0575-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
15 Seiffert DJ, McCarthy Veach P, LeRoy B, Guan W, Zierhut H. Beyond medical actionability: Public perceptions of important actions in response to hypothetical genetic testing results. J Genet Couns 2019;28:355-66. [PMID: 30710467 DOI: 10.1002/jgc4.1048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Benn P, Plon SE, Bianchi DW. Current Controversies in Prenatal Diagnosis 2: NIPT results suggesting maternal cancer should always be disclosed. Prenat Diagn 2019;39:339-43. [PMID: 30398677 DOI: 10.1002/pd.5379] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
17 Yu JH, Appelbaum PS, Brothers KB, Joffe S, Kauffman TL, Koenig BA, Prince AE, Scollon S, Wolf SM, Bernhardt BA, Wilfond BS; Clinical Sequencing Exploratory Research (CSER) Consortium Informed Consent and Governance Working Group. Consent for clinical genome sequencing: considerations from the Clinical Sequencing Exploratory Research Consortium. Per Med 2019;16:325-33. [PMID: 31313633 DOI: 10.2217/pme-2018-0076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
18 Garcia-Herrero S, Simon B, Garcia-Planells J. The Reproductive Journey in the Genomic Era: From Preconception to Childhood. Genes (Basel) 2020;11:E1521. [PMID: 33352697 DOI: 10.3390/genes11121521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Godino L, Varesco L, Bruno W, Bruzzone C, Battistuzzi L, Franiuk M, Miccoli S, Bertonazzi B, Graziano C, Seri M, Turchetti D. Preferences of Italian patients for return of secondary findings from clinical genome/exome sequencing. J Genet Couns 2021;30:665-75. [PMID: 33142017 DOI: 10.1002/jgc4.1350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Scherr CL, Aufox S, Ross AA, Ramesh S, Wicklund CA, Smith M. What People Want to Know About Their Genes: A Critical Review of the Literature on Large-Scale Genome Sequencing Studies. Healthcare (Basel) 2018;6:E96. [PMID: 30096823 DOI: 10.3390/healthcare6030096] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
21 Szego MJ, Meyn MS, Shuman C, Zlotnik Shaul R, Anderson JA, Bowdin S, Monfared N, Hayeems RZ. Views from the clinic: Healthcare provider perspectives on whole genome sequencing in paediatrics. Eur J Med Genet 2019;62:350-6. [PMID: 30503855 DOI: 10.1016/j.ejmg.2018.11.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
22 Ormondroyd E, Mackley MP, Blair E, Craft J, Knight JC, Taylor J, Taylor JC, Wilkie AO, Watkins H. Insights from early experience of a Rare Disease Genomic Medicine Multidisciplinary Team: a qualitative study. Eur J Hum Genet 2017;25:680-6. [PMID: 28327571 DOI: 10.1038/ejhg.2017.37] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
23 Vears DF, Minion JT, Roberts SJ, Cummings J, Machirori M, Murtagh MJ. Views on genomic research result delivery methods and informed consent: a review. Per Med 2021;18:295-310. [PMID: 33822658 DOI: 10.2217/pme-2020-0139] [Reference Citation Analysis]
24 Taher J, Mighton C, Chowdhary S, Casalino S, Frangione E, Arnoldo S, Bearss E, Binnie A, Bombard Y, Borgundvaag B, Chertkow H, Clausen M, Devine L, Faghfoury H, Friedman SM, Gingras AC, Khan Z, Mazzulli T, McGeer A, McLeod SL, Pugh TJ, Richardson D, Simpson J, Stern S, Strug L, Taher A, Lerner-Ellis J. Implementation of serological and molecular tools to inform COVID-19 patient management: protocol for the GENCOV prospective cohort study. BMJ Open 2021;11:e052842. [PMID: 34593505 DOI: 10.1136/bmjopen-2021-052842] [Reference Citation Analysis]
25 Christensen KD, Bernhardt BA, Jarvik GP, Hindorff LA, Ou J, Biswas S, Powell BC, Grundmeier RW, Machini K, Karavite DJ, Pennington JW, Krantz ID, Berg JS, Goddard KAB. Anticipated responses of early adopter genetic specialists and nongenetic specialists to unsolicited genomic secondary findings. Genet Med 2018;20:1186-95. [PMID: 29388940 DOI: 10.1038/gim.2017.243] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
26 Lewis KL, Turbitt E, Chan PA, Epps S, Biesecker BB, Erby LAH, Fasaye GA, Biesecker LG. Engagement and return of results preferences among a primarily African American genomic sequencing research cohort. Am J Hum Genet 2021;108:894-902. [PMID: 33887195 DOI: 10.1016/j.ajhg.2021.04.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Delanne J, Nambot S, Chassagne A, Putois O, Pelissier A, Peyron C, Gautier E, Thevenon J, Cretin E, Bruel AL, Goussot V, Ghiringhelli F, Boidot R, Tran Mau-Them F, Philippe C, Vitobello A, Demougeot L, Vernin C, Lapointe AS, Bardou M, Luu M, Binquet C, Lejeune C, Joly L, Juif C, Baurand A, Sawka C, Bertolone G, Duffourd Y, Sanlaville D, Pujol P, Geneviève D, Houdayer F, Thauvin-Robinet C, Faivre L. Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature. Eur J Med Genet 2019;62:103529. [PMID: 30165243 DOI: 10.1016/j.ejmg.2018.08.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
28 Pullman D, Etchegary H. Ethical, Legal, and Social Issues (ELSI) in Clinical Genetics Research. Methods Mol Biol 2021;2249:65-82. [PMID: 33871839 DOI: 10.1007/978-1-0716-1138-8_5] [Reference Citation Analysis]
29 Lázaro-Muñoz G, Torgerson L, Pereira S. Return of results in a global survey of psychiatric genetics researchers: practices, attitudes, and knowledge. Genet Med 2021;23:298-305. [PMID: 33033403 DOI: 10.1038/s41436-020-00986-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Mackley MP, Capps B. Expect the unexpected: screening for secondary findings in clinical genomics research. Br Med Bull 2017;122:109-22. [PMID: 28398474 DOI: 10.1093/bmb/ldx009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
31 Joffe S, Sellers DE, Ekunwe L, Antoine-Lavigne D, McGraw S, Levy D, Splansky GL. Preferences for Return of Genetic Results Among Participants in the Jackson Heart Study and Framingham Heart Study. Circ Genom Precis Med 2019;12:e002632. [PMID: 31756304 DOI: 10.1161/CIRCGEN.119.002632] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
32 Erger F, Schaaf CP, Netzer C. Which genes to assess in the NGS diagnostics of intellectual disability? The case for a consensus database-driven and expert-curated approach. Mol Cell Probes 2019;45:84-8. [PMID: 30914295 DOI: 10.1016/j.mcp.2019.03.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
33 Etchegary H, Pullman D, Simmonds C, Rahman P. Public interest in unexpected genomic findings: a survey study identifying aspects of sequencing attitudes that influence preferences. J Community Genet. [DOI: 10.1007/s12687-022-00577-0] [Reference Citation Analysis]
34 Henrikson NB, Scrol A, Leppig KA, Ralston JD, Larson EB, Jarvik GP. Preferences of biobank participants for receiving actionable genomic test results: results of a recontacting study. Genet Med 2021;23:1163-6. [PMID: 33603197 DOI: 10.1038/s41436-021-01111-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Sapp JC, Facio FM, Cooper D, Lewis KL, Modlin E, van der Wees P, Biesecker LG. A systematic literature review of disclosure practices and reported outcomes for medically actionable genomic secondary findings. Genet Med 2021. [PMID: 34433902 DOI: 10.1038/s41436-021-01295-7] [Reference Citation Analysis]
36 Ormondroyd E, Mackley MP, Blair E, Craft J, Knight JC, Taylor JC, Taylor J, Watkins H. "Not pathogenic until proven otherwise": perspectives of UK clinical genomics professionals toward secondary findings in context of a Genomic Medicine Multidisciplinary Team and the 100,000 Genomes Project. Genet Med 2018;20:320-8. [PMID: 29261176 DOI: 10.1038/gim.2017.157] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 6.6] [Reference Citation Analysis]
37 Clark CC, Boardman FK. Expanding the notion of “benefit”: comparing public, parent, and professional attitudes towards whole genome sequencing in newborns. New Genetics and Society. [DOI: 10.1080/14636778.2022.2091533] [Reference Citation Analysis]
38 Wouters RHP, van der Graaf R, Rigter T, Bunnik EM, Ploem MC, de Wert GMWR, Dondorp WJ, Cornel MC, Bredenoord AL. Towards a Responsible Transition to Learning Healthcare Systems in Precision Medicine: Ethical Points to Consider. J Pers Med 2021;11:539. [PMID: 34200580 DOI: 10.3390/jpm11060539] [Reference Citation Analysis]
39 Ormond KE, O'daniel JM, Kalia SS. Secondary findings: How did we get here, and where are we going? J Genet Couns 2019;28:326-33. [DOI: 10.1002/jgc4.1098] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
40 Hoell C, Wynn J, Rasmussen LV, Marsolo K, Aufox SA, Chung WK, Connolly JJ, Freimuth RR, Kochan D, Hakonarson H, Harr M, Holm IA, Kullo IJ, Lammers PE, Leppig KA, Leslie ND, Myers MF, Sharp RR, Smith ME, Prows CA. Participant choices for return of genomic results in the eMERGE Network. Genet Med 2020;22:1821-9. [PMID: 32669677 DOI: 10.1038/s41436-020-0905-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
41 Zhu X, Basappa SN, Ridgeway JL, Albertie ML, Pantoja E, Prescott D, Radecki Breitkopf C. Perspectives regarding family disclosure of genetic research results in three racial and ethnic minority populations. J Community Genet 2020;11:433-43. [PMID: 32562160 DOI: 10.1007/s12687-020-00472-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Neu MB, Bowling KM, Cooper GM. Clinical utility of genomic sequencing. Curr Opin Pediatr 2019;31:732-8. [PMID: 31693580 DOI: 10.1097/MOP.0000000000000815] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
43 Willis AM, Terrill B, Pearce A, McEwen A, Ballinger ML, Young MA. My Research Results: a program to facilitate return of clinically actionable genomic research findings. Eur J Hum Genet 2021. [PMID: 34602610 DOI: 10.1038/s41431-021-00973-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Freed AS, Gruß I, McMullen CK, Leo MC, Kauffman TL, Porter KM, Muessig KR, Eubanks D, Goddard KAB, Wilfond BS, Liles EG. A decision aid for additional findings in genomic sequencing: Development and pilot testing. Patient Educ Couns 2021;104:960-8. [PMID: 33191058 DOI: 10.1016/j.pec.2020.10.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
45 Webber EM, Hunter JE, Biesecker LG, Buchanan AH, Clarke EV, Currey E, Dagan-Rosenfeld O, Lee K, Lindor NM, Martin CL, Milosavljevic A, Mittendorf KF, Muessig KR, O'Daniel JM, Patel RY, Ramos EM, Rego S, Slavotinek AM, Sobriera NLM, Weaver MA, Williams MS, Evans JP, Goddard KAB; ClinGen Resource. Evidence-based assessments of clinical actionability in the context of secondary findings: Updates from ClinGen's Actionability Working Group. Hum Mutat 2018;39:1677-85. [PMID: 30311382 DOI: 10.1002/humu.23631] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
46 Graham M, Hallowell N, Solberg B, Haukkala A, Holliday J, Kerasidou A, Littlejohns T, Ormondroyd E, Skolbekken JA, Vornanen M; Northern European Returning Results Network. Taking it to the bank: the ethical management of individual findings arising in secondary research. J Med Ethics 2021:medethics-2020-106941. [PMID: 33441306 DOI: 10.1136/medethics-2020-106941] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Haga SB. Revisiting Secondary Information Related to Pharmacogenetic Testing. Front Genet 2021;12:741395. [PMID: 34659361 DOI: 10.3389/fgene.2021.741395] [Reference Citation Analysis]
48 Gordon DR, Radecki Breitkopf C, Robinson M, Petersen WO, Egginton JS, Chaffee KG, Petersen GM, Wolf SM, Koenig BA. Should Researchers Offer Results to Family Members of Cancer Biobank Participants? A Mixed-Methods Study of Proband and Family Preferences. AJOB Empir Bioeth 2019;10:1-22. [PMID: 30596322 DOI: 10.1080/23294515.2018.1546241] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
49 Eichinger J, Elger BS, Koné I, Filges I, Shaw D, Zimmermann B, McLennan S. The full spectrum of ethical issues in pediatric genome-wide sequencing: a systematic qualitative review. BMC Pediatr 2021;21:387. [PMID: 34488686 DOI: 10.1186/s12887-021-02830-w] [Reference Citation Analysis]
50 Nambot S, Sawka C, Bertolone G, Cosset E, Goussot V, Derangère V, Boidot R, Baurand A, Robert M, Coutant C, Loustalot C, Thauvin-Robinet C, Ghiringhelli F, Lançon A, Populaire C, Damette A, Collonge-Rame MA, Meunier-Beillard N, Lejeune C, Albuisson J, Faivre L. Incidental findings in a series of 2500 gene panel tests for a genetic predisposition to cancer: Results and impact on patients. Eur J Med Genet 2021;64:104196. [PMID: 33753322 DOI: 10.1016/j.ejmg.2021.104196] [Reference Citation Analysis]
51 Mackley MP, Blair E, Parker M, Taylor JC, Watkins H, Ormondroyd E. Views of rare disease participants in a UK whole-genome sequencing study towards secondary findings: a qualitative study. Eur J Hum Genet 2018;26:652-9. [PMID: 29440777 DOI: 10.1038/s41431-018-0106-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
52 Schneider KW, Suttman A, McKinney C, Giller R, Dollerschell K, Nakano TA. Incorporating genetic counseling into the evaluation of pediatric bone marrow failure. J Genet Couns 2021. [PMID: 34570941 DOI: 10.1002/jgc4.1510] [Reference Citation Analysis]
53 Saelaert M, Mertes H, Moerenhout T, De Baere E, Devisch I. Criteria for reporting incidental findings in clinical exome sequencing - a focus group study on professional practices and perspectives in Belgian genetic centres. BMC Med Genomics 2019;12:123. [PMID: 31429751 DOI: 10.1186/s12920-019-0561-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
54 Chad L, Szego MJ. Please give me a copy of my child's raw genomic data. NPJ Genom Med 2021;6:15. [PMID: 33597540 DOI: 10.1038/s41525-021-00175-y] [Reference Citation Analysis]
55 Vu M, Degeling K, Martyn M, Lynch E, Chong B, Gaff C, IJzerman MJ. Evaluating the resource implications of different service delivery models for offering additional genomic findings. Genet Med 2021;23:606-13. [PMID: 33214711 DOI: 10.1038/s41436-020-01030-8] [Reference Citation Analysis]
56 Dheensa S, Carrieri D, Kelly S, Clarke A, Doheny S, Turnpenny P, Lucassen A. A 'joint venture' model of recontacting in clinical genomics: challenges for responsible implementation. Eur J Med Genet 2017;60:403-9. [PMID: 28501562 DOI: 10.1016/j.ejmg.2017.05.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
57 Vornanen M, Aktan-Collan K, Hallowell N, Konttinen H, Kääriäinen H, Haukkala A. "I would like to discuss it further with an expert": a focus group study of Finnish adults' perspectives on genetic secondary findings. J Community Genet 2018;9:305-14. [PMID: 29340884 DOI: 10.1007/s12687-018-0356-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
58 Amendola LM, Robinson JO, Hart R, Biswas S, Lee K, Bernhardt BA, East K, Gilmore MJ, Kauffman TL, Lewis KL, Roche M, Scollon S, Wynn J, Blout C. Why Patients Decline Genomic Sequencing Studies: Experiences from the CSER Consortium. J Genet Couns 2018;27:1220-7. [PMID: 29497922 DOI: 10.1007/s10897-018-0243-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
59 Wouters RHP, Bijlsma RM, Frederix GWJ, Ausems MGEM, van Delden JJM, Voest EE, Bredenoord AL. Is It Our Duty To Hunt for Pathogenic Mutations? Trends Mol Med 2018;24:3-6. [PMID: 29246758 DOI: 10.1016/j.molmed.2017.11.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
60 Meiser B, Guo XY, Putt S, Fullerton JM, Schofield PR, Mitchell PB, Yanes T. Psychosocial implications of living with familial risk of a psychiatric disorder and attitudes to psychiatric genetic testing: A systematic review of the literature. Am J Med Genet B Neuropsychiatr Genet 2020;183:277-88. [PMID: 32369270 DOI: 10.1002/ajmg.b.32786] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Etchegary H, Wilson B, Rahman P, Simmonds C, Pullman D. Public interest in whole genome sequencing and information needs: an online survey study. Personalized Medicine 2020;17:283-93. [DOI: 10.2217/pme-2019-0136] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
62 Vadaparampil ST, Cragun D. Shared decision making: Implications for return of results from whole-exome and whole-genome sequencing. Transl Behav Med 2018;8:80-4. [PMID: 29385585 DOI: 10.1093/tbm/ibx048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
63 Vornanen M, Aktan-collan K, Hallowell N, Konttinen H, Haukkala A. Lay Perspectives on Receiving Different Types of Genomic Secondary Findings: a Qualitative Vignette Study. J Genet Couns 2019;28:343-54. [DOI: 10.1007/s10897-018-0288-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
64 Bijlsma RM, Wessels H, Wouters RHP, May AM, Ausems MGEM, Voest EE, Bredenoord AL. Cancer patients' intentions towards receiving unsolicited genetic information obtained using next-generation sequencing. Fam Cancer 2018;17:309-16. [PMID: 28852913 DOI: 10.1007/s10689-017-0033-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
65 Martyn M, Kanga-parabia A, Lynch E, James PA, Macciocca I, Trainer AH, Halliday J, Keogh L, Wale J, Winship I, Bogwitz M, Valente G, Walsh M, Downie L, Amor D, Wallis M, Cunningham F, Burgess M, Brown NJ, Jarmolowicz A, Lunke S, Goranitis I, Gaff CL; Melbourne Genomics Health Alliance. A novel approach to offering additional genomic findings-A protocol to test a two-step approach in the healthcare system. J Genet Couns 2019;28:388-97. [DOI: 10.1002/jgc4.1102] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
66 Clowes Candadai SV, Sikes MC, Thies JM, Freed AS, Bennett JT. Rapid clinical exome sequencing in a pediatric ICU: Genetic counselor impacts and challenges. J Genet Couns 2019;28:283-91. [PMID: 30964580 DOI: 10.1002/jgc4.1116] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
67 Bijlsma RM, Wouters RHP, Wessels H, May AM, Ausems MGEM, Voest EE, Bredenoord AL. Managing unsolicited findings in genomics: A qualitative interview study with cancer patients. Psychooncology 2018;27:1327-33. [PMID: 29471587 DOI: 10.1002/pon.4676] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
68 Spies G, Mokaya J, Steadman J, Schuitmaker N, Kidd M, Hemmings SMJ, Carr JA, Kuivaniemi H, Seedat S; SHARED ROOTS Group. Attitudes among South African university staff and students towards disclosing secondary genetic findings. J Community Genet 2021;12:171-84. [PMID: 33219499 DOI: 10.1007/s12687-020-00494-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Saelaert M, Mertes H, Moerenhout T, De Baere E, Devisch I. Ethical values supporting the disclosure of incidental and secondary findings in clinical genomic testing: a qualitative study. BMC Med Ethics 2020;21:9. [PMID: 32000764 DOI: 10.1186/s12910-020-0452-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
70 Wagener R, Walter C, Surowy HM, Brandes D, Soura S, Alzoubi D, Yasin L, Fischer U, Dugas M, Borkhardt A, Brozou T. Noncancer-related Secondary Findings in a Cohort of 231 Children With Cancer and Their Parents. J Pediatr Hematol Oncol 2022. [PMID: 35537032 DOI: 10.1097/MPH.0000000000002475] [Reference Citation Analysis]
71 Vears DF, Minion JT, Roberts SJ, Cummings J, Machirori M, Blell M, Budin-Ljøsne I, Cowley L, Dyke SOM, Gaff C, Green R, Hall A, Johns AL, Knoppers BM, Mulrine S, Patch C, Winkler E, Murtagh MJ. Return of individual research results from genomic research: A systematic review of stakeholder perspectives. PLoS One 2021;16:e0258646. [PMID: 34748551 DOI: 10.1371/journal.pone.0258646] [Reference Citation Analysis]
72 Scheuner MT, Russell MM, Chanfreau-Coffinier C, Peredo J, Yano EM, Hamilton AB, Lerner B, Provenzale D, Knight SJ, Voils CI. Stakeholders' views on the value of outcomes from clinical genetic and genomic interventions. Genet Med 2019;21:1371-80. [PMID: 30377384 DOI: 10.1038/s41436-018-0344-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
73 Saelaert M, Mertes H, De Baere E, Devisch I. Incidental or secondary findings: an integrative and patient-inclusive approach to the current debate. Eur J Hum Genet 2018;26:1424-31. [PMID: 29970927 DOI: 10.1038/s41431-018-0200-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
74 Gordon DR, Koenig BA. “If relatives inherited the gene, they should inherit the data.” Bringing the family into the room where bioethics happens. New Genetics and Society. [DOI: 10.1080/14636778.2021.2007065] [Reference Citation Analysis]
75 Saelaert M, Mertes H, Moerenhout T, Van Cauwenbergh C, Leroy BP, Devisch I, De Baere E. A qualitative study among patients with an inherited retinal disease on the meaning of genomic unsolicited findings. Sci Rep 2021;11:15834. [PMID: 34349199 DOI: 10.1038/s41598-021-95258-2] [Reference Citation Analysis]
76 Esplin ED, Haverfield E, Yang S, Aradhya S, Nussbaum RL. Secondary findings on virtual panels: opportunities, challenges, and potential for preventive medicine. Genet Med 2019;21:1250-1. [PMID: 30245515 DOI: 10.1038/s41436-018-0302-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
77 Riedijk S, Diderich K, Galjaard R, Srebniak G. Genome Sequencing in Prenatal Testing and Screening: Lessons Learned From Broadening the Scope of Prenatal Genetics From Conventional Karyotyping to Whole-Genome Microarray Analysis. Clinical Genome Sequencing. Elsevier; 2019. pp. 157-80. [DOI: 10.1016/b978-0-12-813335-4.00010-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
78 Best MC, Butow P, Savard J, Jacobs C, Bartley N, Davies G, Napier CE, Ballinger ML, Thomas DM, Biesecker B, Tucker KM, Juraskova I, Meiser B, Schlub T, Newson AJ. Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting. Eur J Hum Genet 2022. [PMID: 35277654 DOI: 10.1038/s41431-022-01069-y] [Reference Citation Analysis]